Dr. Damiano Rondelli, MD
Claim this profileUniversity of Illinois at Chicago
Studies Sickle Cell Disease
Studies Acute Myelogenous Leukemia
4 reported clinical trials
13 drugs studied
Area of expertise
1Sickle Cell Disease
Stage II
Stage I
2Acute Myelogenous Leukemia
Affiliated Hospitals
Clinical Trials Damiano Rondelli, MD is currently running
Stem Cell Transplant
for Sickle Cell Disease
The study is a Phase II clinical trial. Patients will receive intensity modulated total body irradiation (TBI) at a dose of 3 Gy with standard fludarabine/ i.v. cyclophosphamide conditioning prior to human leukocyte antigen (HLA)-haploidentical hematopoietic stem cell transplant (HSCT). The primary objective of the study is to determine the engraftment at Day +60 following HLA-haploidentical hematopoietic stem cell transplant protocol using immunosuppressive agents and low-dose total body irradiation (TBI) for conditioning and post-transplant cyclophosphamide in patients with sickle cell disease.
Recruiting3 awards Phase 2
Cord Blood Units
for Blood Cancers
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.
Recruiting1 award N/A3 criteria
More about Damiano Rondelli, MD
Clinical Trial Related8 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Damiano Rondelli, MD has experience with
- Fludarabine
- Sirolimus
- ATG
- Cyclophosphamide
- Mycophenolate Mofetil
- Stem Cell Infusion
Breakdown of trials Damiano Rondelli, MD has run
Sickle Cell Disease
Acute Myelogenous Leukemia
Myelodysplastic Syndrome
Acute Myeloid Leukemia
Hodgkin's Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Damiano Rondelli, MD specialize in?
Damiano Rondelli, MD focuses on Sickle Cell Disease and Acute Myelogenous Leukemia. In particular, much of their work with Sickle Cell Disease has involved Stage II patients, or patients who are Stage I.
Is Damiano Rondelli, MD currently recruiting for clinical trials?
Yes, Damiano Rondelli, MD is currently recruiting for 2 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Damiano Rondelli, MD has studied deeply?
Yes, Damiano Rondelli, MD has studied treatments such as Fludarabine, Sirolimus, ATG.
What is the best way to schedule an appointment with Damiano Rondelli, MD?
Apply for one of the trials that Damiano Rondelli, MD is conducting.
What is the office address of Damiano Rondelli, MD?
The office of Damiano Rondelli, MD is located at: University of Illinois at Chicago, Chicago, Illinois 60612 United States. This is the address for their practice at the University of Illinois at Chicago.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.